A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Nightingale Health Oyj, a health technology company, offers advanced health check that detects disease risks in Finland, the United Kingdom, rest of Europe, the United States, and internationally. The company’s Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Remote Health Check where health check done remotely. It also offers blood analysis, self collection kits, urine analysis, and biomarkers services. It provides its services to research programs, universities, and healthcare providers. Nightingale Health Oyj was incorporated in 2002 and is headquartered in Helsinki, Finland.
Financial Summary
| Share Statistics | NHLTY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $66.0 | $1,968.0 | 17% |
|
| Shares Out (Mil) | 71.5 | 77.7 | 55% |
|
| Institutional Ownership | 6.5% | 86.6% | 5% |
|
| Float (Mil) | 29.2 | 52.1 | 35% |
|
| Beta | 0.32 | 0.75 | 19% |
|
| Avg Daily Volume (000s) | 249 | 612 | 47% |
|
| Price Change (52-week) |
na | 79.8% | na |
|
| Growth | NHLTY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 22.4% | 10.9% | 84% |
|
| Net Income (5yr) | (38.9%) | (1.6%) | 10% |
|
| EPS (5yr) | (23.7%) | 0.3% | 11 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 24.2% | (17.9%) | 82% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | NHLTY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $6 | $1,504 | 6% |
|
| Net Income (TTM) (Mil) | ($22) | $28 | 23% |
|
| EPS (TTM) | ($0.371) | $0.200 | 30% |
|
| Operating Cash Flow (TTM) (Mil) | ($13) | $162 | 18% |
|
| Net Cash Flow (TTM) (Mil) | $23 | $9 | 63% |
|
| Long-Term Debt (Q1) (Mil) | $4 | $338 | 23% |
|
| Enterprise Value (Q1) (Mil) | $17 | $2,416 | 10% |
|
| Valuation | NHLTY | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.82 | na |
|
| P/E | na | 26.0 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | NHLTY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 67.4% | 27.8% | 79% |
|
| Net Margin | (397.8%) | 1.2% | 2% |
|
| ROA | (27.6%) | 2.2% | 18% |
|
| ROE | (30.6%) | 7.2% | 20% |
|
| Liabilities to Assets | 13.5% | 58.6% | 8% |
|
| F-Score | na | 5 | na |
|
Nightingale Health Oyj did not pass any screens on 8/21/2026.
